HIKAL vs NGLFINE: Stock Comparison

Hikal Limited vs NGL Fine-Chem Limited

Live data: 22 July 2026, 3:06 PM IST • Source: NSE and company filings

Hikal Limited is the larger company by market capitalisation. Hikal Limited shows a lower P/E and a higher dividend yield, while NGL Fine-Chem Limited shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Hikal Limited and NGL Fine-Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, HIKAL is more favourable on 3 of 13 scored metrics and NGLFINE on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
HIKAL is the larger company
₹2,637 Cr vs ₹2,015 Cr
P/E Ratio
HIKAL has a lower P/E
-56.64x vs 41.23x
P/B Ratio
HIKAL has a lower P/B
2.31x vs 6.03x
EPS
NGLFINE has higher earnings per share
₹78.04 vs ₹-3.95
Dividend Yield
HIKAL has a higher dividend yield
0.44% vs 0.05%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 37.3%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs 68.3%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs -5.97%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHIKALNGLFINE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricHIKALNGLFINE
Live Price₹213.27₹3,260
Day Change-5.1%0.7%
Volume3.55 L5,595
52-Week High₹343.85₹3,329
52-Week Low₹146.25₹1,175.5
Distance from 52W High-37.98%-2.07%

Valuation

MetricHIKALNGLFINE
Market Cap₹2,637 Cr₹2,015 Cr
P/E Ratio-56.64x41.23x
P/B Ratio2.31x6.03x
EPS₹-3.95₹78.04
Book Value₹97.4₹532.95
Dividend Yield0.44%0.05%

Growth

MetricHIKALNGLFINE
Revenue Growth (TTM YoY)37.3%57.2%
EPS Growth (TTM YoY)68.3%1,539.8%
Qtr Sales Growth-5.97%57.1%
Qtr Profit Growth22.5%2,398%

Profitability & Leverage

MetricHIKALNGLFINE
ROE2.95%15.7%
ROCE3.52%17%
Net Margin-2.88%9.59%
Operating Margin12.9%14.5%
Debt to Equity0.57x0.33x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricHIKALNGLFINE
Promoter Holding68.85%72.74%
FII Holding1.43% 0.87 pp0.03% 0.03 pp
DII Holding7.2% 0.15 pp0%
Public Holding22.52% 0.73 pp27.24% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Hikal Limited and NGL Fine-Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.